Sysmex Report 2018 Sysmex 31, 2018 Ended March the Year For

Sysmex Report 2018 Sysmex Report 2018 For the year ended March 31, 2018 1-5-1 Wakinohama-Kaigandori, Chuo-ku, Kobe 651-0073, Japan Tel +81 (78) 265-0500 Fax +81 (78) 265-0524 www.sysmex.co.jp/en/ This brochure was printed in Japan on FSC R-certified paper using non-VOC ink. Lighting the way with diagnostics Lighting the way with diagnostics Sysmex enhances diagnostic value with innovative testing, to bring greater trust and confidence to healthcare. Sysmex operates in the domain of healthcare testing, which involves examining blood, urine and other samples. We provide customers with a variety of products and services, in more than 190 countries and regions. Looking toward the future of healthcare, we are now undertaking new challenges in the field of diagnostics. 1 Sysmex Report 2018 Sysmex Report 2018 2 Corporate Philosophy for the Sysmex Group In line with changes in the global management environment, in we formulated a corporate philosophy for the Sysmex Group, carrying forward and expanding the perspective maintained since the time of our founding. Shaping the advancement of healthcare. We continue to create unique and innovative values, while building trust and confidence. With passion and flexibility, we demonstrate Our founder, Taro Nakatani (right), setting off on his visit to the United States our individual competence and unsurpassed teamwork. An Ideal Unchanged Since Our Founding Dedicated to Supporting People’s Health Our Core Behaviors In , Sysmex founder Taro Nakatani visited the United States, looking for new business ideas. His attention was drawn to the field of medical electronic devices. When he returned to Japan, Mr. Nakatani began working with young researchers, conducting studies and engaging in development. In , they succeeded in the commercialization of Japan’s first hematology analyzer, the CC-. Moving on from this success, TOA MEDICAL ELECTRONICS CO., LTD. (current Sysmex Corpora- tion) was established in . Realizing a healthy society is our ideal. Our corporate culture emphasizes taking on challenges in developing new products and technologies. Furthermore, we have carried forward Sysmex’s values—building trust and confidence among all our stakeholders—since the time of our founding. The CC- automated Founding philosophy (the “Three Aspects of Confidence”) hematology analyzer Total customer confidence in all of our products. Total confidence in our associates in all our business transactions. Total confidence of our employees in themselves and all their work. 3 Sysmex Report 2018 Sysmex Report 2018 4 Hisashi Ietsugu Chairman and CEO To Our Stakeholders We have taken advantage of this timing, our 50th anniversary of establishment, by formulating long-term management goals for Sysmex to take on new challenges and move to the next stage. Based on the “Sysmex Way,” the corporate philosophy of the Sysmex Group, we aim to achieve sustainable growth by creating new testing and diagnostic value as a “Unique & Advanced Healthcare Testing Company.” 5 Sysmex Report 2018 Sysmex Report 2018 6 continued to provide value-added solutions that address Promoting Globalization, customers’ issues and requirements. a Step Ahead of the Times Next, we embarked on transport systems. Nowadays, these systems are commonly used in the hematology field As the size of the testing market is closely linked to popu- to efficiently process tests in large quantities. Sysmex lation, Sysmex moved into the global market early on. led the industry in offering these systems, which were Currently, Sysmex’s market includes all regions of the developed in response to customer feedback, in 1990. world, where more than 7.0 billion people live. These systems set in place the blood to be tested, detect For a certain period after establishment, our business the sample needing to be viewed under a microscope and scale was small, so we pursued globalization via distribu- mount the sample on a glass slide—all automatically. These tors. In 1991, when we had achieved a certain business systems were highly regarded for increasing the productiv- scale, our erstwhile distributor in the United Kingdom ity and safety of testing, addressing the social issues of the decided to cease operations in its healthcare division. We times, namely curtailing healthcare costs and preventing took this move as an opportunity, bringing on employees infection via blood. Nowadays, these systems have become from the distributor and launching our first direct sales, mainstay products. service and support operations overseas. This decision In 1999, we began providing SNCS*, a service utilizing enabled us to hear overseas customers’ issues and needs IT to perform quality control on customers’ instruments, directly, providing a significant boost to our overseas busi- monitor their operating status in real time and support ness. Based on this experience, we put in place direct sales, internal training, and at meetings with individual divisions their stable operation. As testing data is needed for diagno- service and support structures in Germany, the United The Mission Embodying Our Ideal: and in overseas locations in various regions I proactively sis and treatment, testing instrument breakdowns affected States and Asian countries. “Shaping the Advancement of Healthcare” take the opportunity to speak about the “Sysmex Way.” A overall healthcare. Accordingly, reducing the downtime Meanwhile, we began operations in China in the 1990s, The corporate philosophy of the Sysmex Group, the philosophy that has become a mere façade is meaningless, that occurs when instruments break down is extremely before full-fledged economic development had begun. We “Sysmex Way,” has a mission: “Shaping the Advancement of so I make it a point to go back and discuss our philosophy important. SNCS, which detects abnormalities before they developed and sold products tailored to local market needs Healthcare.” This mission embodies the ideal of contribut- on a daily basis. lead to failure, helped to prevent this situation by reducing and held scientific seminars, earning high levels of cus- ing to the development of healthcare and the healthy lives the risk of breakdowns. tomer satisfaction and cultivating our brand image. These of people by bringing new testing and diagnostic technolo- Increasing the value we provide also led to the ad- moves were instrumental in the major business growth we gies into the world. Growing by Continuing to Create Value vancement of our business model. Since the time of our experienced later as the market expanded in line with rapid A variety of healthcare issues exist around the world. establishment, we had provided service and support free of economic growth. I think the key to our business success Advanced countries are characterized by rapidly aging popu- In 2018, we marked the 50th anniversary of Sysmex’s estab- charge as a matter of course, as this was part of selling in- has been our ability to anticipate changes in the business lations, the expectation of extended healthy lifespans and a lishment. Operating performance during this noteworthy struments. However, customers began to understand that environment rather than reacting to changes that have growing need to curtail healthcare costs. At the same time, fiscal year, ended March 31, 2018, was net sales of ¥281.9 by preventing breakdowns, conducting maintenance, offer- already occurred. This capability has helped Sysmex keep a economic advancement in emerging markets and develop- billion (up 12.8% year on year) and operating profit of ¥59.0 ing extensive training and developing services that leverage step ahead of other companies. ing countries is giving rise to growing demands to increase billion (up 14.3%). (Management’s Discussion and Analysis IT, Sysmex was providing value-added service and support. As a result of these ongoing initiatives, Sysmex’s over- the quality of healthcare and eradicate infectious diseases. u P71.) As a result, we were able to turn service and support, which seas business has continued to expand, to the point where We believe that Sysmex’s raison d’être is to face such health- We have grown thanks to the support of a host of was previously a cost center, into the profit center it is to- our overseas sales ratio is currently 84%. care issues and provide solutions that address them. stakeholders, and there are a number of key factors be- day. I believe this sort of business model innovation is one The “Sysmex Way” expresses the core values shared by hind our success. The origins date back to our founding. factor that supports Sysmex’s sustainable growth. all employees who belong to the Sysmex Group. We focus At the time of our founding, in the 1960s, hematology was * Sysmex Network Communication Systems (SNCS): An online support service that connects to the Sysmex Customer Support Center and customers’ instru- on activities to instill the corporate philosophy, so that all generally performed using microscopes. Sysmex was the ments via the Internet to provide real-time external quality control and scien- Sysmex employees around the world progress in the same first company in Japan to automate that process, enhanc- tific information, and monitoring of instrument conditions. direction, based on the “Sysmex Way.” I also participate in ing both productivity and accuracy. Since then, we have 7 Sysmex Report 2018 Sysmex Report 2018 8 boosting competitiveness in our existing mainstay IVD do- where they gained experience and became successful. our quest for sustainable growth, we will continue

Load more